Omniscient Reader Webtoon Receives Anime Adaptation

omniscient reader anime teaser key visual feature image
© Crunchyroll, Aniplex

An anime adaptation of the Korean web novel Omniscient Reader’s Viewpoint was announced during Crunchyroll’s industry panel at Anime Expo 2024. 

The anime will be a co-production between Aniplex and Crunchyroll, with the series listed under the title Omniscient Reader. More details about the adaptation will be announced at a later date. 

omniscient reader anime teaser visual
© Crunchyroll, Aniplex

Crunchyroll will stream the anime adaptation in the following territories: North America, Central America, South America, Europe, Africa, Oceania, the Middle East, CIS, and India. 

The original South Korean web novel is written by Sing Shong and was adapted into a manhwa webtoon by Naver in 2020 with new illustrations by Sleepy-C (Redice Studio). The web novel was published by Munpla from January 6, 2018 to February 2, 2020 for 20 total volumes, while the webtoon released nine volumes. 

LINE Webtoon releases the manhwa in English digitally, while Yen Press releases both the novel and webtoon in English print under the publisher’s Ize Press imprint

omniscient's reader's viewpoint manhwa cover
© Sleepy-C, UMI, singNsong

Crunchyroll describes the synopsis of Omniscient Reader as: 

Dokja was an average office worker whose sole interest was reading his favorite web novel ‘Three Ways to Survive the Apocalypse.’ But when the novel suddenly becomes reality, he is the only person who knows how the world will end. Armed with this realization, Dokja uses his understanding to change the course of the story, and the world, as he knows it.


Source: Crunchyroll News, Crunchyroll Anime Expo Industry Panel 

Want to follow our weekly chart updates and news? Subscribe to our newsletter now!

William Moo is a freelance writer who has previously written for OTAQUEST and MANGA.TOKYO. He enjoys watching lots of anime every season and reading from time to time. You can follow him on Twitter @thewriterSITB.
Leave a Comment!